UNSPSC 51122604: Lovastatin/niacin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV350. This VA Drug Class (CV350) classifies this compound as belonging to the group ANTILIPEMIC AGENTS.

UNSPSC 51122604 Lovastatin/niacin is a Commodity code representing individual pharmaceutical products procured by state and local health agencies, particularly fire-rescue services and state health benefit programs. State and local governments buy specific medication line items under this code to stock emergency medical services, pharmacy benefit programs, and health-plan formularies. Issuing bodies include municipal fire departments (Tampa Fire Rescue), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (MMCAP). The scope spans both direct procurement of emergency life-support medications in small quantities and broader generic pharmaceutical supply agreements through authorized wholesalers serving multiple jurisdictions and facilities.

Recent activity centers on Florida and the multistate cooperative purchasing network anchored in Minnesota, with participation from Oregon. The City of Tampa's Purchasing Department issued IFB 26P00188 on April 24, 2026, soliciting advanced life support medications including labetalol, epinephrine, adenosine, and diltiazem for Tampa Fire Rescue, with bids due April 8, 2026 and an estimated contract value of $40,000, featuring a 5 percent SLBE bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program with responses due the same day. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026, requiring vendors to work through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) and comply with cGMP, DSCSA, and FDA requirements. Contracts awarded under MMCAP will serve participating state and local facilities with a two-year initial term and optional extensions.